| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 58.51× | 58.51× | 50.81× | 58.01× | 42.96× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 11.08× | 10.32× | 14.01× | 10.44× | 9.39× | ||
| 3.41× | 3.41× | 4.03× | 3.46× | 4.73× | ||
| 2.67× | 2.67× | −0.21× | −1.35× | 1.54× | ||
| 1.41× | 1.41× | −0.14× | −0.24× | 0.55× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 42.96 | 58.01 | 50.81 | 58.51 | 58.51 | |
| Working Capital Turnover | 9.39 | 10.44 | 14.01 | 10.32 | 11.08 | |
| Asset Turnover | 4.73 | 3.46 | 4.03 | 3.41 | 3.41 | |
| Cash Conversion (CFO/Net Income) | 1.54 | -1.35 | -0.21 | 2.67 | 2.67 | |
| CFO/EBITDA | 0.55 | -0.24 | -0.14 | 1.41 | 1.41 |